Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

March 24, 2026 · 25 min · Season 24 · Episode 50

About this episode

Experts review data supporting immunotherapy for gastroesophageal cancers and discuss findings from the 2026 ASCO GI Cancers Symposium.

Dr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and moderator Dr Samuel Klempner from Massachusetts General Hospital in Boston review relevant data supporting immunotherapy for patients with gastroesophageal cancers and review recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium. CME information and select publications here .

People in this episode

Host: Dr Samuel Klempner

Guests: Dr Jaffer Ajani, Dr Rutika Mehta, Dr John Strickler

Mentioned in this episode

Organizations: The University of Texas MD Anderson Cancer Center, Weill Cornell Medicine/NewYork-Presbyterian Hospital, Duke University, Massachusetts General Hospital

More episodes of Gastrointestinal Cancer Update

Explore listener stats, chart rankings, contacts and more on the Gastrointestinal Cancer Update podcast page.